Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Sleep quality and other patient‐reported outcomes improve after patients with psoriasis with suboptimal response to other systemic therapies are switched to adalimumab: results from PROGRESS, an open‐label Phase IIIB trial
PaperCitations, authors & open-access status
Sleep quality and other patient‐reported outcomes improve after patients with psoriasis with suboptimal response to other systemic therapies are switched to adalimumab: results from PROGRESS, an open‐label Phase IIIB trial is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 67 citations, 2012 year and bronze oa status.
67
Citations
2012
Year
bronze
OA Status